F
4D Molecular Therapeutics
FDMT
17.200
USD
-0.59
(-3.32%)
مغلق
حجم التداول
10,780
الربح لكل سهم
0
العائد الربحي
0
P/E
-4
حجم السوق
420,433,983
العنوان: 4D Molecular Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.